Christie + Co
Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
Axis-Shield resists new Alere takeover attempt

UK-based diagnostics company Axis-Shield has urged shareholders to resist a fresh takeover attempt by US rival Alere.

In a statement today, Alere repeated its offer to Axis-Shield’s shareholders of 460 pence per share, which was formally made on 5 August. The offer, rejected by the Axis-Shield board, values the business at £230 million.

Alere announced today that it is lowering the threshold of its bid, which had been set at 90% of shareholder acceptance. The company said it now required more than 50% of voting rights, giving it the option of becoming a majority shareholder in Axis-Shield.

The US company also warned that if its offer were to lapse by a deadline of 10 October, “there is a strong possibility that Axis-Shield's share price would fall significantly below its current share price, particularly as no other potential bidder has announced its interest publicly”.

Alere said it was also looking at “alternative acquisitions, particularly in light of current valuations and market conditions”, and that it didn’t necessarily have to acquire Axis-Shield in order to achieve its “strategic objectives”.

In response, Axis-Shield’s board said it was “disappointed” that Alere had not taken notice of the “firm rebuttal” from shareholders to its offer, which it said was clear by the less than 1% level of acceptances that was disclosed in an Alere announcement on 16 September.

“The board has been more than willing to engage with Alere if Alere were to put a proposal to the board that fairly reflected the fundamental value of Axis-Shield. To date, no such proposal has been received from Alere,” said an Axis-Shield statement.

“The company has made excellent progress in the first half of the year and is on track to deliver for the second half of the year. The company believes that Alere is making a highly opportunistic offer in order to try and acquire Axis-Shield on the cheap.”

The 460 pence per share offer price represents a premium of 37% on the closing share price of 335 pence on 5 July 2011 – the last business day before Alere revealed it was considering an approach.
 

Posted on: 26/09/2011

Latest news stories

30/03/2017
The 16 hospital trusts selected to lead the digital transformation of NHS organisations as ‘global digital exemplars’ will not receive any investment this financial year from a promised £100-million pot.
30/03/2017
The Welsh government will invest an additional £20 million in social care in 2017-18, it announced this week.
30/03/2017
Care home operator Renaissance Care has secured a £4.5 million debt facility from Barclays.
30/03/2017
Global private hospital group Ramsay has appointed Craig McNally to succeed current chief executive Chris Rex.
29/03/2017
Circle Holdings saw a group revenue rise of 4.4% during the full year ended 31 December 2016, the company’s audited results, published today, have revealed.




Interview: Paolo Pieri

After a first decade or so rarely out of the limelight, Circle's next act is all about scale, CEO Paolo Pieri tells Ploy Radford
Read more...



Company profile: IMH Group

IMH CEO Richard Power tells Sarah Williams how the company is taking the strain off the struggling primary care sector
Read more...
HealthInvestor Events

Social care staffing' already under strain, could face further pressure after Brexit. Sarah Williams asks sector leaders about their biggest fears - and what could allay them
Read more...


Christie + Co


Learning disabilities

The CQC has been accused of 'unlawfully' refusing to register LD units with over six beds. Ploy Radford takes a look at the issue which has got the LD sector up in arms
Read more...



HealthInvestor blog
Some may be looking to leave healthcare but we should take heart that many are still actively interested

Click here to view the Editor's blog


Claire Smith is the chief executive of HCA Joint Ventures and an avid dog walker
Dr Michelle Tempest and Dr Niklas Jahn of Candesic diagnose the investment case for the orthopaedic hip and knee joint replacement market
Clare Connell and Henry Hunt of Connell Consulting take a look at how rising fuel costs will affect health and social care
Social care staffing, already under strain, could face further pressure after Brexit. Sarah Williams asks sector leaders about their biggest fears – and what could allay them
IMH CEO Richard Power tells Sarah Williams how the company is taking the strain off the struggling primary care sector

Click here to search all feature articles